Method of producing submicron particles of a labile agent and use thereof
First Claim
1. A method for preparing a composition for the sustained release of a labile agent, comprising the steps of:
- a) forming a suspension comprising human growth hormone complexed to a stabilizing metal cation and dispersed in a polymer solution comprising at least one biocompatible polymer and at least one polymer solvent;
b) wet milling the suspension to achieve submicron particles of the labile agent; and
c) removing the polymer solvent thereby forming a solid polymer matrix having the labile agent dispersed therein.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a sustained release composition comprising micron particles of labile agent and a method of preparing and using the sustained release composition. The invention further relates to micron particles of a labile agent and a method of preparing the micron particles. The method of the invention for preparing a composition for the sustained release of a labile agent, comprises forming a suspension comprising the labile agent dispersed in a polymer solution comprising at least one biocompatible polymer and at least one polymer solvent. The suspension is then wet milled to achieve micron particles of the labile agent. The polymer solvent is then removed resulting in a solid polymer/labile agent matrix. The method for preparing micron particles of a labile agent comprises forming a suspension comprising the labile agent, dispersed in a polymer solution comprising at least one biocompatible polymer and at least one polymer solvent, and wet milling of the suspension.
32 Citations
108 Claims
-
1. A method for preparing a composition for the sustained release of a labile agent, comprising the steps of:
-
a) forming a suspension comprising human growth hormone complexed to a stabilizing metal cation and dispersed in a polymer solution comprising at least one biocompatible polymer and at least one polymer solvent;
b) wet milling the suspension to achieve submicron particles of the labile agent; and
c) removing the polymer solvent thereby forming a solid polymer matrix having the labile agent dispersed therein. - View Dependent Claims (2, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
20. The method of claim 19 wherein the mechanical means is a dispersion mill or rotary blender.
-
21. The method of claim 20 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
22. The method of claim 1 wherein the polymer solvent is selected from the group consisting of:
- methylene chloride, acetone, ethyl acetate, methyl acetate, chloroform, dimethylsulfoxide, hexafluoroisopropanol or a combination thereof.
-
3. A method for preparing a composition for the sustained release of a labile agent, comprising the steps of:
-
a) forming a suspension comprising the labile agent wherein the labile agent is a protein, polypeptide or oligonucleotide dispersed in a polymer solution comprising a poly(lactide-co-glycolide) polymer and at least one polymer solvent;
b) wet milling the suspension to achieve submicron particles of the labile agent; and
c) removing the polymer solvent thereby forming a solid polymer matrix having the labile agent dispersed therein. - View Dependent Claims (23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
34. The method of claim 33 wherein the mechanical means is a dispersion mill or rotary blender.
-
35. The method of claim 34 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
36. The method of claim 3 wherein the polymer solvent is selected from the group consisting of:
- methylene chloride, acetone, ethyl acetate, methyl acetate, chloroform, dimethylsulfoxide, hexafluoroisopropanol or a combination thereof.
-
4. A method for preparing a composition for the sustained release of a labile agent, comprising the steps of:
-
a) forming a suspension comprising the labile agent wherein the labile agent is a protein, polypeptide or oligonucleotide dispersed in a polymer solution comprising at least one biocompatible polymer and a polymer solvent selected from the group consisting of methylene chloride, chloroform, acetone, ethyl acetate, methyl acetate, dimethylsulfoxide, hexafluoroisopropanol and any combinations thereof;
b) wet milling the suspension to achieve submicron particles of the labile agent; and
c) removing the polymer solvent thereby forming a solid polymer matrix having the labile agent dispersed therein. - View Dependent Claims (6, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
50. The method of claim 49 wherein the mechanical means is a dispersion mill or rotary blender.
-
51. The method of claim 50 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
5. A method for preparing a composition for the sustained release of a labile agent, comprising the steps of:
-
a) forming a suspension comprising the labile agent wherein the labile agent is a protein, polypeptide or oligonucleotide dispersed in a polymer solution comprising at least one biocompatible polymer and at least one polymer solvent;
b) wet milling the suspension to achieve submicron particles of the labile agent;
c) adding a metal cation component to the suspension which modulates the release of the labile agent; and
d) removing the polymer solvent thereby forming a solid polymer matrix having the labile agent dispersed therein. - View Dependent Claims (52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
65. The method of claim 64 wherein the mechanical means is a dispersion mill or rotary blender.
-
66. The method of claim 65 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
67. The method of claim 5 wherein the polymer solvent is selected from the group consisting of:
- methylene chloride, acetone, ethyl acetate, methyl acetate, chloroform, dimethylsulfoxide, hexafluoroisopropanol or a combination thereof.
-
7. A method for preparing submicron particles of a labile agent, wherein said method comprises the steps of:
-
a) forming a suspension comprising the labile agent wherein the labile agent is a protein, polypeptide or oligonucleotide dispersed in a polymer solution comprising a poly(lactide-co-glycolide) polymer and at least one polymer solvent; and
b) wet milling the suspension. - View Dependent Claims (68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 88, 89, 90, 91)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
79. The method of claim 78 wherein the mechanical means is a dispersion mill or rotary blender.
-
80. The method of claim 79 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
81. The method of claim 7 wherein the polymer solvent is selected from the group consisting of:
- methylene chloride, acetone, ethyl acetate, methyl acetate, chloroform, dimethylsulfoxide, hexafluoroisopropanol or a combination thereof.
-
88. The method of claim 7 wherein the labile agent is a protein.
-
89. The method of claim 88 wherein the protein is complexed to a stabilizing metal cation.
-
90. The method of claim 89 wherein said stabilizing metal cation is selected from the group consisting of Zn+2, Ca+2, Cu+2, Mg+2, K+and any combination thereof.
-
91. The method of claim 90 wherein said stabilizing metal cation is Zn+2.
-
8. A method for preparing submicron particles of a labile agent, wherein said method comprises the steps of:
-
a) forming a suspension comprising the labile agent wherein the labile agent is a protein, polypeptide or oligonucleotide dispersed in a polymer solution comprising at least one biocompatible polymer and a polymer solvent selected from the group consisting of methylene chloride, acetone, ethyl acetate, methyl acetate, chloroform, dimethylsulfoxide, hexafluoroisopropanol and any combination thereof; and
b) wet milling the suspension. - View Dependent Claims (82, 83, 84, 85, 86, 87, 92, 93, 94, 95, 96)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
95. The method of claim 94 wherein the mechanical means is a dispersion mill or rotary blender.
-
96. The method of claim 95 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
9. A method for preparing submicron particles of a labile agent, wherein said method comprises the steps of:
-
a) forming a suspension comprising human growth hormone complexed to a stabilizing metal cation and dispersed in a polymer solution comprising at least one biocompatible polymer and at least one polymer solvent; and
b) wet milling the suspension. - View Dependent Claims (10, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108)
a) adding a grinding media to the suspension; and
b) applying a mechanical means.
-
-
106. The method of claim 105 wherein the mechanical means is a dispersion mill or rotary blender.
-
107. The method of claim 106 wherein the dispersion mill is selected from the group consisting of:
- a rotary mill, a ball mill, an attrition mill, a vibratory mill, a planetary mill, a media mill or a bead mill.
-
108. The method of claim 9 wherein the polymer solvent is methylene chloride, acetone, ethyl acetate, methyl acetate, chloroform, dimethylsulfoxide, hexafluoroisopropanol and a combination thereof.
Specification